<DOC>
	<DOCNO>NCT02709356</DOCNO>
	<brief_summary>Evaluate compare change brain ketone glucose uptake take two different MCT oil emulsion ( 60-40 oil C8 oil ) one month , group people Alzheimer 's disease control group .</brief_summary>
	<brief_title>Medium Chain Triglycerides Brain Metabolism Alzheimer 's Disease</brief_title>
	<detailed_description>Based PET/MRI protocol , aim study evaluate compare response dietary supplementation two different MCT oil ( 60 % C10 + 40 % C8 100 % C8 ) two group , patient Alzheimer 's disease healthy elderly people ( N=10/group ) . After baseline evaluation , participant test one supplement two successive period one month ; period time end 18F-FDG 11C-acetoacetate PET scan .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Good general health Control group Diagnosis Alzheimer 's disease ( NINCDSADRDA criterion ) AD group Depression Medical psychiatric condition could interfere study participation Fasting plasma glucose â‰¥7.0 mM ( diabetes prediabetes ) Already MCT supplementation Clinicallysignificant gastrointestinal disease/conditions Clinicallysignificant liver disease/dysfunction Clinicallysignificant renal disease/dysfunction Clinicallysignificant cardiac disease/conditions Hypertension Uncontrolled dyslipidaemia Vitamin B12 deficiency Structured physical activity ( 3 times/week )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>